Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

BACKGROUND: Several drugs are available to treat metastatic renal-cell carcinoma (MRCC), and predictive markers to identify the most adequate treatment for each patient are needed. Our objective was to identify potential predictive markers of sunitinib activity in MRCC. METHODS: We collected sequent...

Full description

Saved in:

Bibliographic Details
Main Authors:	Perez-Gracia, J L, Prior, C, Guillén-Grima, F, Segura, V, Gonzalez, A, Panizo, A, Melero, I, Grande-Pulido, E, Gurpide, A, Gil-Bazo, I, Calvo, A
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 2009
Subjects:	Translational Therapeutics
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2788252/ https://ncbi.nlm.nih.gov/pubmed/19904265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605409
Tags:	Add Tag No Tags, Be the first to tag this record!

Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

Similar Items